| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |